Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$50,000.00
Feb 4, 2021
For-profit organization
Multi-language Support for the Winterlight Assessment App
969026
Given the number of
clinical trial sites in different countries across the world, the following languages were identified as top-priorities from
the business perspective: 1) Spanish, 2) French, 3) German.
$50,000.00
Feb 1, 2021
For-profit organization
Powered wheelchair training and assessment platform
965533
It will provide new training opportunities to those who are learning how to drive by offering driving insights to therapists and caregivers. It can also help clinical researchers studying various aspects of wheelchair use such as activity and participation.
$2,282,176.00
Feb 1, 2021
For-profit organization
COVID-19-Treatment for lung injury
966019
This project represents important steps of the full non-clinical FB100 development program which will lead to clinical trials in early 2022.
$303,341.00
Jan 21, 2021
Academia
Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines
964417
This research will pave the way toward a human clinical trial.
$303,341.00
Jan 21, 2021
Academia
Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines
964417
This research will pave the way toward a human clinical trial.
$342,500.00
Jan 20, 2021
217056
217056
Purchase manufacturing equipment to improve production efficiencies and product quality
$1,000.00
Jan 19, 2021
Other
2021-HQ-000124
2021-HQ-000124
Not a Project (Mandated or Core Funding)
$10,000,000.00
Jan 19, 2021
Academia
816107
816107
The project will capitalize on the strong pipeline of health tech companies that is emerging in southwestern Ontario to connect them with an integrated suite of services ranging from mentorship and business advisory services, support for health tech product development, and access to specialized labs and clinical trial spaces at the University of Waterloo’s planned Innovation Arena and at Western University.
$528,234.00
Jan 15, 2021
Not-for-profit organization or charity
Transduced t cells for pre-clinical development of novel cd22 car-t’s
969531
This project build on the success of the work done over the last two years in establishing clinical grade manufacturing for both lentivirus and cell products, and in executing the first clinical trial using a made-in-Canada CD19 CAR T-cell therapy. The overarching goal of the Project is to build much needed capacity in point-of-care (POC) manufacturing to support the clinical rollout of novel CAR T-cell products and other personalized cell therapy products with the addition of new POC manufacturing and clinical sites.
$50,000.00
Jan 15, 2021
For-profit organization
Hypothesis Validation for a Point-of-care urinalysis platform for at-home metabolic monitoring
964334
Herstasis Health Inc is developing a clinical Point-of-Care urinalysis invitro medical diagnostic device.